New Analyst Forecast: $C Given 'Overweight' Rating

We just received data on a new analyst forecast for $C. Morgan Stanley gave a rating of 'Overweight' for $C.

$C Analyst Ratings

Wall Street analysts have issued reports on $C in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Overweight" rating on 06/24/2025
• Goldman Sachs issued a "Buy" rating on 06/24/2025
• Oppenheimer issued a "Outperform" rating on 05/20/2025
• RBC Capital issued a "Outperform" rating on 04/16/2025
• Wolfe Research issued a "Outperform" rating on 01/03/2025
• Wells Fargo issued a "Overweight" rating on 01/03/2025

To track analyst ratings and price targets for $C, check out Quiver Quantitative's $C forecast page.

$C Price Targets

Multiple analysts have issued price targets for $C recently. We have seen 2 analysts offer price targets for $C in the last 6 months, with a median target of $81.0.

Here are some recent targets:

• Gerard Cassidy from RBC Capital set a target price of $78.0 on 04/16/2025
• An analyst from Truist Financial set a target price of $84.0 on 04/04/2025

$C Congressional Stock Trading

Members of Congress have traded $C stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $C stock by members of Congress over the last 6 months:

• REPRESENTATIVE BRUCE WESTERMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/03 and 1 sale worth up to $15,000 on 04/21.
• REPRESENTATIVE GEORGE WHITESIDES sold up to $50,000 on 03/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$C Insider Trading Activity

$C insiders have traded $C stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.

Here’s a breakdown of recent trading of $C stock by insiders over the last 6 months:

• MARK MASON (Chief Financial Officer) sold 58,465 shares for an estimated $4,864,790
• EDWARD SKYLER (Hd of Ent Svc & Public Affairs) sold 35,545 shares for an estimated $2,929,263
• SYED SHAHMIR KHALIQ (Head of Services) has made 0 purchases and 5 sales selling 30,000 shares for an estimated $2,451,124.
• ANAND SELVAKESARI (Chief Operating Officer) has made 0 purchases and 2 sales selling 30,000 shares for an estimated $2,433,146.
• BRENT MCINTOSH (Chief Legal Off. & Corp. Sec'y) has made 0 purchases and 3 sales selling 20,000 shares for an estimated $1,624,453.
• SARA WECHTER (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 15,125 shares for an estimated $1,225,284.
• JOHN CUNNINGHAM DUGAN sold 4,417 shares for an estimated $301,492

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$C Hedge Fund Activity

We have seen 1,018 institutional investors add shares of $C stock to their portfolio, and 936 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL WORLD INVESTORS added 15,576,685 shares (+49.7%) to their portfolio in Q1 2025, for an estimated $1,105,788,868
• BERKSHIRE HATHAWAY INC removed 14,639,502 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $1,039,258,246
• BANK OF AMERICA CORP /DE/ added 12,491,399 shares (+60.9%) to their portfolio in Q1 2025, for an estimated $886,764,415
• GOLDMAN SACHS GROUP INC added 7,728,438 shares (+113.6%) to their portfolio in Q1 2025, for an estimated $548,641,813
• NORGES BANK added 6,611,226 shares (+31.7%) to their portfolio in Q4 2024, for an estimated $465,364,198
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 6,433,746 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $452,871,380
• ROYAL BANK OF CANADA removed 6,229,794 shares (-34.4%) from their portfolio in Q1 2025, for an estimated $442,253,076

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.